Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.30 |
| ▸ | DRD1 | P21728 | 2/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.30 |
| ▸ | DRD3 | P35462 | 2/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.30 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8712088 | 0.75 | CYP1A2 (0.39) | ADRA2AS1PR4S1PR1S1PR3S1PR5 | |
| Iodide SCHEMBL8712885 | 0.72 | CHRNB2 (0.30) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL8711864 | 0.72 | CPN1 (0.46) | METAP1SMN1; SMN2LMNACYP2D6TSHR | |
| SCHEMBL23160555 | 0.71 | INPP5A (0.40) | SMN1; SMN2GFERCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL23160556 | 0.71 | INPP5A (0.40) | SMN1; SMN2GFERCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL8711893 | 0.70 | ATM (0.32) | SMN1; SMN2GFERCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL8712189 | 0.70 | CACNA2D1 (0.33) | SMN1; SMN2S1PR1S1PR3S1PR5 | |
| SCHEMBL29252680 | 0.69 | SMN1; SMN2 (0.38) | SMN1; SMN2GFERCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL25660551 | 0.69 | GFER (0.39) | SMN1; SMN2GFERCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL9925436 | 0.68 | CHRM2 (0.38) | SMN1; SMN2GFERCHRNB2CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1255501-A | Novel phosphonyl sulfonic ester compound and its medicinal compsns. | PROCTER & GAMBLE PHARMA (US) | 2000-06-07 | — | — | CN | disclosed |
| CN-1229083-A | Novel phosphononosulfonate compounds and its pharmaceutical compositions | PROCTER & GAMBLE PHARMA (US) | 1999-09-22 | — | — | CN | disclosed |
| EP-0642518-B1 | PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM | PROCTER & GAMBLE PHARMA (US) | 1998-08-05 | — | — | EP | disclosed |
| US-5731299-A | OSTEOPOROSIS; RHEUMATOID ARTHRITIS | THE PROCTER & GAMBLE COMPANY (US) | 1998-03-24 | — | — | US | disclosed |
| EP-0642518-A1 | PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM | PROCTER & GAMBLE PHARMACEUTICALS (US) | 1995-03-15 | — | — | EP | disclosed |
| CN-1087640-A | Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism | PROCTER & GAMBLE PHARMA (US) | 1994-06-08 | — | — | CN | disclosed |
| WO-1993024495-A1 | PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM | PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) | 1993-12-09 | — | — | WO | disclosed |